Buy and Hold: These Well-Known Retailers Promise Huge Future Returns

September 18, 2023

We can all see that the US relies heavily on consumption—which has been the case for years—and revenue from the retail sector plays a vital role in determining the state of the economy.

Inflation and rising interest rates in recent years have certainly affected growth in the retail sector, and overall sentiment regarding retail stocks has been mostly tepid among investors.

However, US retail sales increased by 0.7% in July. With inflation starting to settle and the holiday season soon approaching, there’s an argument to be made for investing in undervalued retail stocks. The ones I’ll cover today could also be considered passive income stocks due to their very lucrative dividend payouts.

With plenty of reasons to be optimistic about retail stocks, analysts think they have the potential to yield up to 50% in total returns by 2025, easily surpassing index returns…

Home Depot (HD)

Home Depot (HD) is a compelling choice among undervalued retail stocks, poised for an upward breakout. Despite a predicted decline of 2% in sales and 5% in comparable sales for 2023, HD maintains impressive financial stability, boasting a huge amount of free cash flow. This financial strength allows flexibility for investments, share buybacks, and dividends, as evident in HD’s recently authorized $15 billion share repurchase program. HD remains bullish on expanding its market share within the extensive retail market, and with ample resources for investments, it has strong long-term growth potential.

HD is up year-to-date by 4.39% and is trading around the middle of its 52-week high-low range. With a 0.95 beta score, which indicates safety from broader market volatility, HD has a positive 20/200 day SMA (simple moving average), an operating free cash flow of $12.75 billion, and a remarkable ROE (return on equity) of 2,065%. For its Q2 2023 earnings call, HD reported EPS of $4.65 per share vs. $4.44 per share as expected by analysts, a 4.68% surprise; it also beat analysts on revenue estimates by 1.63%. For the current fiscal quarter, HD is projected to post $37.6 billion in sales at $3.77 per share, with a 3-5 EPS growth rate of 13.5%. HD has an annual dividend yield of 2.54%, a quarterly payout of $2.09 ($8.39/year) per share, and a 51% payout ratio. With a 10-day average volume of 2.58 million shares, HD has a median price target of $350, with a high of $384 and a low of $296; this could lead to a 16.5% price increase.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”HD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Target (TGT)

Target (TGT), another prominent retailer, has encountered challenges, with a 5.4% year-over-year decline in comparable store sales for Q2 2023. Despite this setback, though, there are notable bright spots. In Q2, TGT also achieved a 27% gross margin, marking a 550 basis point improvement. As inflation eases, sustained margin enhancement is anticipated. Additionally, with the holiday season on the horizon, 2023’s second half is expected to yield positive results, potentially driving TGT upward from its undervalued position. TGT‘s ambitious $4 to $5 billion investment plan for 2023, focused on enhancing the guest experience, remodeling existing stores, and diversifying its brand portfolio, is positioned to yield favorable outcomes. TGT also works well as an excellent income stock with its handsome dividend.

TGT is currently down year-to-date by 16.27%, is trading near the very bottom of its existing 52-week range, carries a 1.01 beta, has a PEG (price/earnings to growth) ratio of 0.93x, and has an operating free cash flow of $7.46 billion. TGT, for its Q2 earnings call, reported EPS of $1.80 per share vs. $1.42 per share as expected by analysts, a 26.85% win. During the same period, TGT also reported year-over-year growth in net income (+356.28%), EPS (+361.54%), net profit margin (+381.43%), and operating income (+254.99%). For the current quarter, TGT is projected to post $26.5 billion in sales at $2.02 per share, with a 3-5 year EPS growth rate of 5.6%. With a 3.53% annual dividend yield, TGT has a quarterly payout of $1.10 ($4.40/year) per share and a 59.62% payout ratio. Having a 10-day average volume of 3.23 million shares, TGT has a median price target of $142.80, with a high of $184 and a low of $120; this indicates the potential for a price jump of over 47% from its current trading position.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TGT” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Best Buy (BBY)

Last but certainly not least is Best Buy (BBY), and it’s worth considering adding to your portfolio as another undervalued retailer. BBY has maintained stability in the past year and boasts an appealing forward P/E ratio of 11x. Projections suggest BBY stock could bring total returns ranging from 30% to 40% in the next two years. BBY’s outlook anticipates a turning point in tech demand, with growth expected to surge due to natural upgrade and replacement cycles. This suggests a positive shift away from sales declines, and given BBY’s valuation and current trading position, there’s undoubtedly room for growth. Like its peers on the list, there’s an attractive dividend to be had by holding a piece of BBY.

Currently down year-to-date by 8.44%, BBY is trading around the bottom end of its existing 52-week range, has a 1.33x PEG ratio, a positive ROE of 45%, and a reasonably low D/E (debt to equity) figure of 40.92%. BBY carries a TTM (trailing twelve-month) free cash flow of $1.44 billion. BBY, for its Q2 2023 earnings call, reported EPS of $1.22 per share vs. $1.07 per share as predicted by analysts (a 13.35% win); it also beat revenue estimates, albeit slightly, by a 0.69% margin. For the current quarter, BBY is projected to report sales of $10 billion at $1.24 per share, with a 3-5 year EPS growth rate of 8%. BBY has a 5.01% annual dividend yield, a quarterly payout of 92 cents ($3.68/year) per share, and a 62.07% payout ratio. With a 10-day average volume of 2.19 million shares, BBY has a median price target of $81, with a high of $91 and a low of $70; this indicates the potential for a nearly 25% increase from its current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”BBY” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Three Stocks to Sell ASAP

Editorial Staff

September 16, 2023

The right stocks can make you rich and change your life.

The wrong stocks, though… They can do a whole lot more than just “underperform.” If only! They can eviscerate your wealth, bleeding out your hard-won profits.

They’re pure portfolio poison.

Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media – until it’s too late.

That’s not to suggest they’re obscure companies – some of the “toxic stocks” I’m going to name for you are, in fact, regularly in the headlines for other reasons, often in glowing terms.

I’m going to run down the list and give you a chance to learn the names of three companies I think everyone should own instead.

But first, if you own any or all of these “toxic stocks,” sell them today…

Mullen Automotive (MULN)

Mullen Automotive has experienced a staggering 99.96% decline since November 2021, making it a prime example of a speculative investment gone awry.

MULN share price surged by 80% last week due to a stock buyback program. This and any future spikes can be viewed as a selling opportunity stock.

The company’s CEO recently expressed skepticism about the stock price’s alignment with the actual company value, emphasizing steady operational progress and the initiation of commercial vehicle production. However, interpreting market signals suggests a lack of investor confidence in the management team. Amid increasing revenue, the ongoing cash burn and the need for equity dilution raise concerns. The timing of the buyback initiative is puzzling, given the company’s apparent need for funds to support growth ventures.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MULN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Windtree Therapeutics (WINT)

Windtree Therapeutics, a Pennsylvania-based biotech firm, specializes in addressing advanced-stage cardiovascular disorders like cardiogenic shock and acute heart failure.

However, the current year hasn’t been favorable for the company. Windtree’s stock has experienced an 85% decline, largely attributed to its chairman, James Huang’s resignation. Huang’s departure was accompanied by statements that the company’s stock price doesn’t accurately reflect its intrinsic value. Moreover, the transfer of ownership shares from existing shareholders was acknowledged as a misstep.

The second quarter saw Windtree reporting a net loss of $6.6 million, equivalent to $1.64 per share. While the quarter generated $12.4 million in funds, the company has enough liquidity to maintain operations until the first quarter of 2024.

With five drugs in its pipeline, four of them in Phase 2 testing, WINT stock is positioned for potential growth. Ideally, the company aims to achieve revenue generation before its financial resources deplete in the upcoming year. However, if this milestone isn’t met, the possibility of seeking additional funds, potentially through equity dilution, looms.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”WINT” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Marvell Technology (MRVL)

According to Marvell Technology’s CEO, Matt Murphy,, generative AI is playing a pivotal role in attracting fresh investments from the company’s cloud-focused clientele.

Not surprisingly, MRVL stock witnessed a notable surge earlier in the summer, fueled by expectations of it emerging as a major player in the AI stock realm. However, the actual outcome has consistently fallen short of these optimistic projections.

Illustrating this, the company released its earnings report on August 24th. The company not only incurred a financial loss but also experienced an 11% year-over-year dip in revenues. Despite the touted AI revolution, it seems that Marvell is missing out on the AI momentum. With disappointing earnings and waning enthusiasm for its AI prospects, MRVL stock seems poised for a downward trajectory.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MRVL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Semiconductor Revolution: The Impact of ARM’s Landmark IPO

Editorial Staff

September 16, 2023

The fiscal year 2023 on Wall Street has mostly acted as a highlighter of a new, never-before-seen technology boom, and it’s starting to have a far-reaching global impact on many industries.

This enormous tech rally was kicked off by the launch of OpenAI’s ChatGPT, a generative AI (artificial intelligence) model that has since inspired a swath of competitors offering their own innovations.

As AI plays an increasingly important role in our lives, there will also be more opportunities for investors. Some of those opportunities are already here and present themselves with a very lucrative appeal.

There was one business that played an extraordinarily vital role in the manufacturing of chips, or semiconductors, that many of us weren’t aware of—until now, that is…

ARM, a UK-based pioneer in chip design, took center stage on September 14th, 2023, as it embarked on its long-awaited initial public offering (IPO). It was quite a sight and rather unexpected for many; this IPO was the largest on record since 2021, netting roughly $4.87 billion in fundraising.

With its roots tracing back to 1990, when it emerged as a joint venture between Acorn Computers, Apple, and VLSI Technology, ARM has “been there, done that,” if you will. Those in the know, including ARM’s backers and managers, are convinced that it’s poised for remarkable expansion in the years to come.

Arm Holdings, initially the brainchild of SoftBank, staged an introduction on Wall Street that made immediate waves. ARM cast its opening spell with a staggering valuation of nearly $60 billion, and what ensued was the sale of roughly 95.5 million of its shares. SoftBank, the entity that ushered ARM into the private realm in 2016, retained over 90% of the outstanding shares.

ARM’s day range:

[stock_market_widget type=”gauge” template=”basic” assets=”ARM” low_high=”day_low_high” red_color=”#DB2828″ yellow_color=”#FBBD08″ green_color=”#21BA45″ api=”yf”]

ARM set its share price at the higher end of the anticipated range. After Thursday’s opening bell, ARM’s stock commanded an impressive opening trading price of $56.10 and closed the day at $63.59.

ARM’s P/E (price to earnings) ratio leaped to over 110x based on the latest year’s profits. An engaging comparison could be drawn to Nvidia (NVDA), which trades at a 108x P/E ratio. However, ARM lacks NVDA’s staggering 170% growth forecast for the current quarter. That’s for now, at least. ARM’s CFO (Chief Financial Officer), Jason Child, has emphasized its strategic focus on nurturing growth and crafting products that offer “more for less” to its varied clientele.

[stock_market_widget type=”comparison” template=”basic” color=”#5679FF” assets=”ARM,NVDA” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘ARM’:{},’NVDA’:{}}” display_currency_symbol=”true” api=”yf” chart_range=”5d” chart_interval=”1d”]

A significant slice of ARM’s royalties originates from already prominent products. Remarkably, around half of the company’s $1.68 billion in royalty revenue for 2022 is attributed to products that made their debut between 1990 and 2012. Child eloquently likened these enduring products to the timeless Beatles discography, continually delivering royalties despite their vintage status.

In an intriguing pitch to investors, ARM shared its vision for the company, foreseeing the total market for its chip designs skyrocketing to a staggering $250 billion by 2025. This would be a huge advantage for data centers and automobiles. Also, ARM’s prowess is the backbone of nearly every smartphone chip, revealing how intricate a processor can be with its arithmetic, algorithms, and access to memory.

Notably, ARM distributed $735 million worth of its shares to a group of strategic investors, including tech titans like Alphabet, Nvidia, Apple, Samsung, AMD, Intel, and Taiwan Semiconductor, to name a few. This move is a testament to ARM’s commanding influence, as chip companies have embraced its technology to assist in their contributions to the industry.

SoftBank CEO Masayoshi Son has accentuated ARM’s role in fueling the AI revolution and how involved the business has already been in AI and ML (machine learning). He passionately expressed that he planned to hold SoftBank’s stake in ARM for the foreseeable future.

ARM’s debut can breathe fresh life into the technology IPO market, which had been in hibernation for nearly two years. This event marks the most monumental and influential tech offering in quite some time, heralding an era of enthusiasm for a new wave of AI-based technology that will indeed act as a change agent in each of our lives for years to come.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ARM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Forget Canopy Growth Corp (CGC), These Cannabis Stocks are Poised to Win

Editorial Staff

September 15, 2023

President Joe Biden’s recent directive to review the classification of marijuana in the United States has sent ripples through both the cannabis industry and Capitol Hill. Historically, cannabis policy has been associated with left-wing causes, often met with strong opposition from Republicans. However, in what Bloomberg describes as a “rare moment of progress,” the notion of rescheduling marijuana is gaining traction from both sides of the political spectrum. This newfound optimism is fueling interest and enthusiasm in cannabis stocks.

As the industry awaits updates on potential rescheduling, investors are closely monitoring the cannabis sector, and one notable development is the remarkable surge in shares of Canada-based Canopy Growth (TSX: WEED), which have risen by almost 200% since late August. However, despite these gains, Canadian cannabis producers continue to face substantial challenges. Over the last four fiscal years, Canopy Growth has reported cumulative operating losses of nearly $3 billion, causing its share prices to plummet by 98% from all-time highs.

Amid this shifting landscape, two companies poised to benefit significantly from potential rescheduling are Green Thumb Industries (GTBIF) and Curaleaf Holdings (CURLF).

Green Thumb Industries (GTBIF)

In contrast to their Canadian counterparts grappling with various issues, multi-state operators like Green Thumb are fortifying their profit margins and positioning themselves to capitalize on economies of scale, particularly if marijuana legalization gathers momentum.

Green Thumb, with a market capitalization of $3.5 billion, strategically focuses on limited-license markets in the U.S., where competition is constrained to a select few. This strategy has enabled Green Thumb to cultivate a dedicated customer base and consistently achieve positive GAAP results for 11 consecutive quarters, setting it apart from other players in the cannabis industry. During the second quarter (Q2), Green Thumb reported sales of US$252 million, a GAAP net income of US$13 million, and an adjusted EBITDA of US$76 million, demonstrating a robust 30% margin. The company’s strong operating cash flow of US$93 million and cash reserves of US$149 million at the end of Q2 underscore its financial stability. With plans to expand its Rise retail stores, Green Thumb is projected to achieve an 18% increase in sales, reaching $1.36 billion in 2023, and a 16.3% rise in revenue to $1.6 billion in 2024. Analysts anticipate adjusted earnings to grow from $0.44 per share in 2022 to $0.57 per share in 2024, despite macroeconomic challenges. With a price-to-forward-sales ratio of 2.2 and a price-to-forward-earnings ratio of 25.6, GTBIF stock presents an enticing valuation, trading at a substantial discount to consensus price target estimates.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GTBIF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Curaleaf Holdings (CURLF)

If marijuana receives reclassification as Schedule III, it could usher in a new era for medical cannabis, aligning it with pharmaceutical regulations. This transformation would be particularly advantageous for companies like Green Thumb and Curaleaf, both of which operate in this space.

Curaleaf, boasting a market cap of $4.8 billion, has experienced a remarkable 64% surge since late August. Much like Green Thumb, Curaleaf operates as a multi-state operator, with a presence in 20 states. The company manages 22 cultivation sites and 152 retail outlets, positioning itself for international expansion through strategic acquisitions. For instance, in the fourth quarter of 2022, Curaleaf secured a 55% equity stake in Four 20 Pharma, a leading medical cannabis company in Germany. With annual sales in Europe estimated at US$248 billion, Curaleaf is well-positioned to drive sales growth over the next decade, especially given its 2022 revenue of $1.77 billion. If rescheduling moves forward, Curaleaf could see its stock sustainably surpass the $5 mark, firmly establishing itself among the top cannabis stocks.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CURLF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Concerns from China: How Apple (AAPL) Can Persevere and Maintain Market Strength

Editorial Staff

September 11, 2023

Apple (AAPL) recently encountered a challenging week anticipating the iPhone 15 launch.

Shares declined for several days over concerns about potential disruptions in AAPL’s sales in China. This is due to China’s government essentially banning public officials from using iPhones at work.

However, it’s essential to weigh this against the positive impact of AAPL’s iPhone 15 launch. By the way, can you believe they’re now on the fifteenth one?! This is exciting for both consumers and investors.

It’s also important to remember that AAPL’s shares have seen surges on both a year-to-date and year-over-year basis. They also maintain a strong balance sheet and earnings history…

From a fundamental perspective, concerns about the iPhone ban for Chinese government employees must be assessed, and the apprehension is undoubtedly warranted. It’s been estimated that this ban may impact less than 500,000 devices, a relatively small amount compared to the approximately 45 million iPhones projected to be sold in China over the next year.

China represents roughly 19% of AAPL’s revenue, which has played a significant role in supporting Chinese jobs. Therefore, it is actually unlikely that the Communist Party would take drastic action against AAPL.

While concerns loom over AAPL’s business in China, it’s important to remember that China plays a notable role in its success. As investors, however, we also need to remember that AAPL has a proven history of adapting to the global market, Wall Street sentiment, and broad market issues.

Currently, AAPL’s stock is up year-to-date by 37.20% but is trading near the middle of its existing 52-week range; this means the stock is already showing healthy returns but still has room to grow and prosper. AAPL has a positive 20/200 day SMA (simple moving average), huge TTM (trailing twelve-month) momentum growth, and an ROE (return on equity) of more than 160%. Although losing a small chunk of its $3 trillion market capitalization, AAPL still carries a free cash flow of just over $90 billion.

AAPL 52-week range:

[stock_market_widget type=”gauge” template=”basic” assets=”AAPL” low_high=”52_week_low_high” red_color=”#DB2828″ yellow_color=”#FBBD08″ green_color=”#21BA45″ api=”yf”]

For its Q2 2023 earnings call, AAPL reported an EPS of $1.26 per share vs. $1.19 per share as expected by analysts, beating their projections by a 5.49% margin; they met revenue projections evenly. During the same period, AAPL posted year-over-year growth in net income (+2.26%), EPS (+5%), and net profit margin (+3.71%). For the current fiscal quarter, AAPL is expected to report $90.3 billion in sales at $1.36 per share, with a 3-5 year EPS growth rate of 21.5%. They’re slated to report again on October 26th.

AAPL has more to offer as well, with its annual dividend yield of 0.54% and a quarterly payout of 24 cents ($0.96/year) per share. While the bonus that comes with AAPL being a decent income stock, there are plenty of reasons, as I’ve mentioned, that cause bullish sentiment among bloggers and analysts. With a 10-day average volume of 61 million shares, AAPL has a median price target of $202, with a high of $240 and a low of $160; this represents a potential price jump of just about 35% from where it is currently. As assigned by analysts, AAPL has 11 strong buy ratings, 20 buy ratings, and 11 hold ratings.

Investors may be tempted to sell their shares due to the recent developments, but it’s crucial to recognize that AAPL’s success doesn’t solely rely on one product—not even the iPhone. AAPL has consistently demonstrated its ability to innovate and adapt to changing environments, a quality that has contributed to

its remarkable growth over several decades. This adaptability suggests that AAPL will continue to find new avenues for growth, even while facing challenges such as those posed by the China-related situation.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AAPL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Stock Hotlist: Top Picks for the Coming Week

Editorial Staff

September 10, 2023

Picking the wrong stocks can decimate your portfolio.

They’re pure portfolio poison.

But the right stocks…

If you pick the right stocks, you could find yourself jumping for joy on top of an enormous pile of cash.

With over 4000 tickers to choose from, finding the right stock at the right time can prove to be nearly impossible…

Unless you’re spending hours each day combing the markets and researching companies.

That’s why we’ve done the legwork for you.

We sort through thousands of stock ideas and whittle them down to a few top choices that are primed for solid price action in the coming days, weeks and months.

This week, we’ve narrowed it down to three stocks that could be getting significant attention in the near future.

Meta Platforms (META)

Meta seems to have rediscovered its momentum, which bodes well for investors. Following a challenging 2022, the parent company of Facebook and Instagram has witnessed its stock price surge by 145% this year. The company is steering away from the metaverse, adopting cost-cutting measures, and emphasizing its focus on artificial intelligence (AI). In the wake of the impact of high interest rates, META stock is now indicating a robust return to growth, positioning it as one of the potential stocks to make investors millionaires.

Furthermore, the social media powerhouse has recently released financial results that have revitalized confidence in both the company and its shares. After the Q2 earnings report, META stock soared by 8%, fueled by earnings per share of $2.98, exceeding the projected $2.91 estimated by analysts. The company generated $32 billion in revenue, surpassing consensus predictions of $31.12 billion. This growth is attributed to a rebound in digital advertising across its social media platforms. Q2 revenue experienced an 11% surge from the previous year, marking the first time the company has reported double-digit growth in this domain since the conclusion of 2021. It might just be the right time to consider a purchase.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”META” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Enbridge (ENB)

The spotlight has turned toward prominent Canadian energy transportation firm Enbridge due to its perceived undervaluation, evidenced by a 13.68% dip over the past year against a consensus price target that indicates plenty of room for growth.

Enbridge holds a significant position as a blue-chip dividend stock, boasting a substantial 7.2% yield. Notably, Enbridge is dedicated to delivering value to its shareholders, having accumulated savings of $1.2 billion since 2017. With a BBB+ credit rating, the company assures stability within the dynamic energy sector. Moreover, Enbridge’s historical resilience and strategic approach to debt utilization for capital investments contribute to its overall stability. The company’s strategic emphasis on natural gas aligns well with the evolving energy landscape, making it a potentially promising avenue for investors seeking to enhance their investment foundation.

Enbridge’s distinction among oil stocks stems from its expansive North American pipeline network. While recent stock fluctuations have occurred, the company’s fundamental role in energy infrastructure, coupled with a moderate buy consensus, hints at an appealing 18% upside potential for investors considering this opportunity.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ENB” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Accenture (ACN)

Recent developments have spotlighted the synergistic collaboration between Accenture and Nvidia, culminating in the launch of AI Lighthouse, harnessing Nvidia’s formidable AI supercomputing expertise. It’s evident that Accenture is not merely riding the AI wave but is also setting a trailblazing pace for others in the industry.

Accenture has showcased remarkable performance in 2023, marking a surge of approximately 16% year-to-date. This growth trend is solidifying its position as a compelling machine learning stock, catching the attention of many astute investors.

The recent release of third-quarter fiscal 2023 earnings has only reinforced this positive outlook. A robust revenue of $16.56 billion, exhibiting a 2.5% year-on-year increase, in combination with a net income of $2.01 billion, reflecting a substantial 13% growth, underscore the company’s operational prowess. Moreover, the diluted earnings per share (EPS) have significantly expanded by 13%, surpassing expectations by an impressive margin of 5%.Accenture’s proactive endeavors in the realm of AI and machine learning have been garnering significant attention. For investors with a discerning eye on high-potential machine learning stocks, Accenture is effectively illuminating the path toward a transformative AI-driven future.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ACN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Three Stocks to Sell ASAP

Editorial Staff

September 6, 2023

The right stocks can make you rich and change your life.

The wrong stocks, though… They can do a whole lot more than “underperform.” If only! They can eviscerate your wealth, bleeding out your hard-won profits.

They’re pure portfolio poison.

Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media – until it’s too late.

That’s not to suggest they’re obscure companies – some of the “toxic stocks” I’m going to name for you are, in fact, regularly in the headlines for other reasons, often in glowing terms.

I’m going to run down the list and give you a chance to learn the names of three companies I think everyone should own instead.

But first, if you own any or all of these “toxic stocks,” sell them today…

Big Lots (BIG)

With a sprawling inventory ranging from toys and clothing to household essentials and even groceries, Big Lots has etched its presence across more than 1,400 locations.

However, the tides haven’t been in Big Lots’ favor in the year 2023. With an inflationary breeze blowing, one might expect the company to thrive, as value-conscious individuals typically seek refuge in discount havens.

Yet, the path has been strewn with hurdles for Big Lots. Rather than basking in prosperity, the company grappled with augmented costs, the looming specter of higher interest rates, and the vexing entanglements of supply chain issues. As the landscape shifted, even the customary refuge of tax refunds took a hit, courtesy of the 2022 tax year, curtailing the spending vigor of patrons within the halls of Big Lots stores.

Dividend investors were also let down as the company reacted to these pressures by suspending its 30-cent-per-share dividend.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”BIG” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Fisker (FSR)

In the competitive electric vehicle (EV) industry, survival is tough for startups. Although Fisker has begun delivering its EVs, it’s just the beginning, and challenges lie ahead. The EV market is crowded, with many established players.

While Fisker reported record revenue from Ocean SUV deliveries, it reduced its production target to 20,000-23,000 vehicles from 32,000-36,000. Q2 deliveries were only 11 EVs, generating $825,000 in revenue. Operating expenses reached $128 million; capital expenses were $91.3 million. The stock is now at $5.86, down 14% this year from $10 in August 2022.

Though Fisker has started production, its long-term outlook is uncertain. The recent termination of a stock offering adds to concerns. While it might have cash to continue for a year, the bigger picture doesn’t look promising. Consider selling FSR stock before it falls further.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”FSR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Telus Corp. (TU)

Telus Corp. is one stock to steer clear of post-earnings. The Canadian company experienced a drastic 60% decline in profit and swiftly decided to slash 6,000 jobs. This workforce reduction includes 4,000 positions at its Vancouver headquarters and 2,000 more across its international operations, including the U.S. The announcement followed Telus’ report of a 60% year-over-year drop in Q2 net income, which settled at $196 million.

Adding to the unfavorable picture, the net income of 14 cents per share fell short of analysts’ projections of 22 cents per share. Despite a 13% increase in revenue from $4.40 billion to $4.95 billion compared to the previous year, the company’s profitability remained challenged. Telus had already revised down its annual 2023 guidance in July before the Q2 release due to demand pressures and the need for cost-cutting measures. The revised forecast now anticipates revenue growth of 9.5% to 11.5% for the year, down from the earlier estimate of 11% to 14%.

With TU stock experiencing a 23% decline over the past 12 months and a 3% decrease over a five-year span, it’s evident that this stock is best avoided following its Q2 earnings report.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TU” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Your Ultimate Gold Stock Watchlist

Editorial Staff

September 6, 2023

In a world of financial uncertainty and volatile markets, astute investors are constantly on the lookout for safe-haven assets that can weather economic storms and preserve their wealth. Among these precious gems of the investment world, gold stands tall as the timeless guardian of value and security. As economies ebb and flow, one thing remains certain – the allure of gold as a haven for investors seeking stability.

Are you ready to embark on a journey of potential prosperity, guided by the glimmer of precious metals? Look no further, for we have meticulously curated a definitive Gold Stock Watchlist that reveals the hidden treasures within the ever-shining realm of gold investments.

Gold Fields Ltd. (GFI)

First up, we have Gold Field Limited, a major gold mining firm based in the heart of Johannesburg, South Africa. Now, what sets GFI apart? Well, its geopolitical status is nothing short of intriguing. With international relations being a bit shaky in certain resource-rich regions, GFI’s strategic positioning could spell opportunity for investors. Plus, their extensive mining operations reach across the Americas, Australia, and West Africa, adding even more allure to the mix.

The eleven analysts offering 12-month price forecasts for Gold Fields Ltd have a median target of 14.62, with a high estimate of 18.00 and a low estimate of 10.92. The median estimate represents a +8% increase from the last price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GFI” start_expanded=”false” display_currency_symbol=”true” api=”yf”]

Agnico Eagle Mines Ltd. (AEM)

Next in line is Agnico Eagle Mines, hailing from the Great White North, Canada. This senior gold mining company boasts production activities in multiple countries, including Finland, Mexico, and the U.S. But what’s really got our attention is Agnico’s rock-solid financials and its no-nonsense policy of not selling future gold production forward. Now, that’s a bold move! With analysts singing praises for its profitability, AEM stands out among the best gold mining stocks to buy.

The seventeen analysts offering 12-month price forecasts for Agnico Eagle have a median target of 68.20, with a high estimate of 73.69 and a low estimate of 55.00. The median estimate represents a +35% increase from the last price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AEM” start_expanded=”false” display_currency_symbol=”true” api=”yf”]

Seabridge Gold Inc (SA)

And for the risk-takers among us, let’s turn our eyes to Seabridge Gold. This Canadian-based player is gunning for the development of a mega gold-silver-molybdenum-copper mine in the scenic northwest British Columbia. What excites us is Seabridge’s claim of having one of the world’s largest resources of gold, copper, and silver. With the future holding tantalizing possibilities like mass integration of EVs, Seabridge’s potential could skyrocket. But remember, my friends, this is a speculative bet, so tread carefully.

The three analysts offering 12-month price forecasts for Seabridge Gold have a median target of 34.36, with a high estimate of 60.00 and a low estimate of 33.50. The median estimate represents a +177% increase from the last price of 12.41.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”SA” start_expanded=”false” display_currency_symbol=”true” api=”yf”]

Silicon Valley Billionaire’s Investment Strategy Might Be the Perfect Fit for 2023

Editorial Staff

September 6, 2023

Gain insights into how Chamath Palihapitiya navigates the complex world of finance with a visionary’s mindset, and gain an exclusive glimpse into his strategic playbook.

In the ever-evolving world of tech investing, there are few figures as intriguing and influential as Chamath Palihapitiya. A former Facebook executive turned venture capitalist, Palihapitiya’s journey has been nothing short of remarkable. But what sets him apart is not just his success; it’s his distinctive approach to investing that has captivated the attention of seasoned investors and newcomers alike.

His investment strategy goes beyond the conventional norms of the market. He’s not just seeking returns; he’s in pursuit of groundbreaking innovations that have the potential to reshape industries. His focus lies in identifying companies that aren’t just following trends but are pioneering transformative technologies. It’s a strategy that requires patience, a keen understanding of market dynamics, and, above all, an unwavering belief in the power of disruptive innovation.

Continue to the full article, where we’ll uncover Palihapitiya’s investment secrets and gain insights into how he navigates the complex world of finance with a visionary mindset, and gain an exclusive glimpse into his strategic playbook.

[stock_market_widget type=”accordion” template=”chart” color=”#5679FF” assets=”META” start_expanded=”true” display_currency_symbol=”true” api=”yf” chart_range=”max” chart_interval=”1wk”]

Renowned for his contrarian and long-term investment approach, Palihapitiya seeks out companies that tackle colossal challenges with innovative solutions driven by the belief in technologies that can revolutionize industries and create enduring value. He once affirmed, “You want to invest in companies that fundamentally change an industry and take a very long view.”

His investment philosophy pivots around early identification of technological disruptions, advocating for cutting-edge sectors like artificial intelligence, space exploration, and biotechnology. The core principle is to look past short-term market flux and concentrate on the potential of groundbreaking technologies; as he puts it, “Investing is about figuring out what the world is going to look like.”

A risk-taker unafraid to back unconventional ideas, Palihapitiya’s investments in ventures like Virgin Galactic, Clover Health, and Opendoor reflect his willingness to challenge norms. He urges investors to stand by their choices, even if they diverge from popular sentiment. “Great investors have to make bets that are lonely,” he advises, underscoring the power of conviction.

[stock_market_widget type=”comparison” template=”basic” color=”#5679FF” assets=”SPCE,CLOV,OPEN” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘SPCE’:{},’CLOV’:{},’OPEN’:{}}” display_currency_symbol=”true” api=”yf” chart_range=”1y” chart_interval=”1d”]

Palihapitiya’s investment counsel revolves around patience and grasping fundamental industry shifts. His emphasis rests on recognizing the long-term potential of disruptive technologies, as opposed to fleeting market trends. Notably, stating, “The market is the most powerful, efficient mechanism for transferring wealth from the impatient to the patient,” he also underscores diversification as well as avoiding an overconcentration of investments.

In a world where innovation is driving change at an unprecedented pace, Chamath Palihapitiya’s investment philosophy offers a refreshing perspective. His focus on transformative technologies and his readiness to take calculated risks have solidified his reputation as an investor who not only follows trends but shapes them. Aspiring investors can draw inspiration from his journey and approach to navigating the ever-evolving investing world. Here are Palihapitiya’s current top holdings:

Blue-Chip Dividends: Top Stocks Trading Below Fair Value

Editorial Staff

September 5, 2023

Within the realm of investment strategies and emerging market trends, blue-chip dividend stocks stand out. These industry leaders boast stability, renowned brands, and generous dividends, making them a low-risk option when seeking profitability.

Opportunities await the astute investor, and I’ve found a few that tick all the boxes when it comes to finding attractive blue-chip names. These popular buy-rated stocks are undervalued, and each shows a promising price upside…

General Dynamics Corp (GD)

General Dynamics (GD) is a prominent defense contractor that has solidified its position within its industry. GD’s primary point of focus is the operation of its “Gulfstream” commercial jet program, which excels in manufacturing high-quality, long-range private jets. The luxury goods market has experienced a global upswing in recent years, propelling demand for GD’s planes. Additionally, the allure of private jets has grown further since the pandemic, with more affluent folks hopping on board.

Despite GD’s strong numbers, its stock is down year-to-date by 14.89% and it’s trading near the bottom of its existing 52-week range. GD has a safe 0.83 beta score. GD shows TTM revenue of $40 billion at $12.22 per share, profiting $3.39 billion in net income via its 8.50% profit margin. GD has an ROE of 18.27%, a PEG ratio of 1.77x, a P/S (price to sales) ratio of 1.47x, and a D/E (debt to equity) of 63.38%. GD most recently bested analysts’ projections on EPS and revenue by 1.84% and 6.20%, respectively. GD has a 2.50% annual dividend yield and a quarterly payout of $1.32 ($5.28/year) per share. With roughly $2 billion in free cash flow, GD has a median price target of $252.50, with a high of $325 and a low of $218, suggesting a price leap of over 54% from where it is now. GD has 19 buy ratings and six hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Danaher Corp (DHR)

Another one to consider is Danaher Corp. (DHR), a top blue-chip stock focused on healthcare that was initially an industrial conglomerate but has since strategically navigated mergers and acquisitions, resulting in remarkable returns. As it concludes the spin-off of its water division, DHR will solely concentrate on healthcare, particularly in the growing bioprocessing market. While sales dipped after the pandemic, this presents an attractive entry point for investors to get a piece of DHR.

Down by 11.57% year-to-date, DHR is at the bottom of its 52-week range with a beta score of 0.80. DHR shows a TTM revenue of $30.95 billion at $9.29 per share, and it has made a net income of $6.85 billion on the back of its 22.40% profit margin. DHR has a PEG ratio of 2.17x, an ROE of 14.17%, and a D/E (debt to equity) of 40.66%. At its last earnings call, DHR reported EPS of $2.36 per share vs. $2.26 as predicted by analysts, beating their forecasts by 4.36%; it also beat revenue by a 1.59% margin. DHR has an annual dividend yield of 0.46% and a quarterly payout of 27 cents ($1.08/year) per share. With a 10-day average volume of 3.35 million shares, DHR has a median price target of $273, with a high of $328 and a low of $220, representing a potential price jump of nearly 40%. DHR has 21 buy ratings and seven hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”DHR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Goldman Sachs Group Inc (GS)

I don’t shy away from reality in the markets. This year, Goldman Sachs (GS) has faced some challenges. The banking industry crisis and concerns over GS’s performance have contributed to slower operations, particularly affected by sluggish capital market conditions in 2022. However, there are reasons to remain optimistic about GS. Market conditions are rebounding, and the resurgence of high-profile IPOs, like Cava (CAVA), is expected to revive demand for GS’s services. Furthermore, Goldman is positioned for significant growth in its consumer business. GS’s dividend certainly sticks out:

GS’s stock is currently down by 8.60% and is near the bottom of its range. From $44.67 billion in TTM revenue at $28.08 per share, GS has profited $1.97 billion via a 22.63% net margin. With a PEG ratio of 0.7x, GS most recently reported EPS at $8.79 per share vs. $8.06 per share, as projected by analysts, beating their forecasts by a 9.08% margin. GS has an annual dividend yield of 3.19% and a quarterly payout of $2.50 ($10.00/year) per share. With $37 billion in operating free cash flow and a 10-day average volume of 2.65 million shares, GS has a median price target of $385, with a high of $470 and a low of $305; this indicates the potential for a nearly 50% price upside. GS has 17 buy ratings and nine hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GS” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

1...444546...67 Page 45 of 67

Home Depot (HD)

Target (TGT)

Best Buy (BBY)

Mullen Automotive (MULN)

Windtree Therapeutics (WINT)

Marvell Technology (MRVL)

Green Thumb Industries (GTBIF)

Curaleaf Holdings (CURLF)

AAPL 52-week range:

Meta Platforms (META)

Enbridge (ENB)

Accenture (ACN)

Big Lots (BIG)

Fisker (FSR)

Telus Corp. (TU)

Gold Fields Ltd. (GFI)

Agnico Eagle Mines Ltd. (AEM)

Seabridge Gold Inc (SA)

Gain insights into how Chamath Palihapitiya navigates the complex world of finance with a visionary’s mindset, and gain an exclusive glimpse into his strategic playbook.

General Dynamics Corp (GD)

Danaher Corp (DHR)

Goldman Sachs Group Inc (GS)

Popular Posts

My Favorites